Literature DB >> 216115

Recent studies on the role of the immune response in resistance to virus-induced leukemias and lymphomas.

D Meruelo, H O McDevitt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 216115

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  6 in total

1.  Lack of class I H-2 antigens in cells transformed by radiation leukemia virus is associated with methylation and rearrangement of H-2 DNA.

Authors:  D Meruelo; R Kornreich; A Rossomando; C Pampeno; A Boral; J L Silver; J Buxbaum; E H Weiss; J J Devlin; A L Mellor
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 2.  Role of the major histocompatibility complex in resistance to viral leukemia; its effect on the preleukemic stage of leukemogenesis.

Authors:  P Lonai; E Katz; N Haran-Ghera
Journal:  Springer Semin Immunopathol       Date:  1982

3.  Murine leukemia virus sequences are encoded in the murine major histocompatibility complex.

Authors:  D Meruelo; R Kornreich; A Rossomando; C Pampeno; A L Mellor; E H Weiss; R A Flavell; A Pellicer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

4.  In vivo or in vitro treatments with anti-I-J alloantisera abolish immunity to AKR leukemia.

Authors:  D Meruelo; N Flieger; D Smith; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

5.  T- and B-cell determination in various lymphoid tissues of mice during N-nitrosobutylurea (NBU) leukemogenesis.

Authors:  M Kraus; G R Krueger
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

6.  Growth of SJL/J-derived transplantable reticulum cell sarcoma as related to its ability to induce T-cell proliferation in the host. I. Dominant negative genetic influences of other parent haplotype in F1 hybrids of SJL/J mice.

Authors:  I R Katz; S P Lerman; N M Ponzio; D C Shreffler; G J Thorbecke
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.